# Revascularization for peripheral artery disease (angioplasty, stenting, bypass)

Intervention · id `cardio:revascularization-for-peripheral-artery-disease-angioplasty-stenting-bypass` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Peripheral artery revascularization; Endovascular treatment of peripheral artery disease; Bypass surgery for peripheral artery disease; Percutaneous transluminal angioplasty (PTA)

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

Revascularization is the group of procedures, open surgery or endovascular treatment, used on narrowed or blocked arteries in peripheral artery disease. Reviews describe bypass surgery and endovascular treatment (procedures done from inside the blood vessels) as the mainstream treatments. One review of endovascular options calls percutaneous transluminal angioplasty one of the mainstays of endovascular therapy and says stents have evolved to include bare metal, covered and drug-eluting types. The reviews also say the best choice between surgical and endovascular approaches is still debated, and one says not all people with chronic limb-threatening ischemia are suitable for revascularization.

## Technical summary

MeSH Endovascular Procedures (D057510, broad): its scope note describes minimally invasive procedures done within the blood vessels, which is wider than peripheral artery treatment; the scope note does not mention bypass surgery. The record rests on that scope note and on three open-access reviews (PMC10095037, PMC12786405 and PMC7043107, all CC BY 4.0). The reviews' trial results, pooled effect estimates, device results and conclusions in favour of one approach are not repeated here, and the atlas states no recommendation of when to use either approach. Strategy page; the evidence recorded is descriptive and comes from reviews, with no study data of its own.

## Claims, with the population each applies to

## Context: People with peripheral artery disease, including limb-threatening disease (MeSH scope note and three reviews)

Recipient: Recipient not specified; Population: People with peripheral artery disease considered for treatment of blocked leg arteries, as the MeSH scope note and the reviews describe them. One review is about chronic limb-threatening ischemia and another about disease below the groin (infrainguinal); neither is a single study population.; Care setting: Vascular surgery and endovascular treatment, as the reviews describe them.; Geography: Not stated for the reviews as a whole.; Life stage: Adults are implied but not stated. This record makes no statement about pregnancy, newborns or children.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (reviews of treatment approaches; follow-up periods of individual studies are not recorded).

### MeSH describes endovascular procedures as minimally invasive procedures performed within the blood vessels. A 2025 systematic review (Journal of Clinical Medicine) calls bypass surgery and endovascular treatment the mainstream treatments for peripheral artery disease and says the choice of treatment varies and the best approach has been a subject of ongoing controversy; it also says guidelines widely recommend endovascular therapy for infrainguinal disease despite a lack of adequately powered data. A 2020 review (F1000Research) describes percutaneous transluminal angioplasty as one of the mainstays of endovascular therapy and says stents have evolved to include bare metal, covered and drug-eluting types. A 2023 review of chronic limb-threatening ischemia says there is still a lack of consensus on the best treatment strategy and that not all patients are suitable for revascularization.

- Category: Description
- Evidence stage: Evidence synthesis
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: People with peripheral artery disease considered for treatment of blocked leg arteries, as the MeSH scope note and the reviews describe them. One review is about chronic limb-threatening ischemia and another about disease below the groin (infrainguinal); neither is a single study population.; Care setting: Vascular surgery and endovascular treatment, as the reviews describe them.; Geography: Not stated for the reviews as a whole.; Life stage: Adults are implied but not stated. This record makes no statement about pregnancy, newborns or children.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (reviews of treatment approaches; follow-up periods of individual studies are not recorded).
- Limitations: Reviews that describe approaches and their debate. Pooled effect estimates, trial results, device results and each review's own conclusion about which approach to prefer are not repeated and not assessed, and the atlas makes no recommendation. The sources do not define bypass surgery beyond naming it, and they cover different parts of the leg arteries.
- Last checked: 2026-11-18
- Sources:
  1. Background: Chronic Limb-Threatening Ischemia and the Need for Revascularization (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2023;12), fetched 2026-11-18. A narrative review. Used for what chronic limb-threatening ischemia is, the hemodynamic measures named in its diagnosis, and the limits the review states on choosing a revascularization strategy; the trial results, classification thresholds and guideline details it discusses are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC10095037/>
     Locator: Abstract, Background, sentence 4. Retrieved 2026-11-18T17:27:04Z. Source state: Current. Version fingerprint: 1bf40be5eee462217350ea27e088333d0294ff4fdbe1136b6cffc5edd8f9f7bb.
     How it applies: In chronic limb-threatening ischemia the review says there is still a lack of consensus on the best treatment strategy.
  2. Supports: Chronic Limb-Threatening Ischemia and the Need for Revascularization (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2023;12), fetched 2026-11-18. A narrative review. Used for what chronic limb-threatening ischemia is, the hemodynamic measures named in its diagnosis, and the limits the review states on choosing a revascularization strategy; the trial results, classification thresholds and guideline details it discusses are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC10095037/>
     Locator: Abstract, Results, sentence 2 (part). Retrieved 2026-11-18T17:27:04Z. Source state: Current. Version fingerprint: 1bf40be5eee462217350ea27e088333d0294ff4fdbe1136b6cffc5edd8f9f7bb.
     How it applies: The review says not all patients with chronic limb-threatening ischemia are suitable for revascularization.
  3. Supports: MeSH scope note for descriptor D057510 (Endovascular Procedures) (Dataset, edition MeSH linked-data record of the preferred concept M0537674 of descriptor D057510, fetched 2026-11-08. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0537674>
     Locator: scopeNote.@value, sentence 1. Retrieved 2026-11-08T20:37:38Z. Source state: Current. Version fingerprint: 3237ee241ca87299b9cc6f99d562e52f5e731dd23f37dbdaf183f420a0f6fc54.
     How it applies: MeSH: endovascular procedures are minimally invasive procedures performed within the blood vessels.
  4. Supports: Endovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2025;15), fetched 2026-11-18. A systematic review and meta-analysis. Used only for how the review describes the mainstream treatments for peripheral artery disease and its statement that the best approach is debated; its pooled odds ratios, hazard ratios and its conclusion are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC12786405/>
     Locator: 1. Introduction, para 2, sentence 1. Retrieved 2026-11-18T17:27:07Z. Source state: Current. Version fingerprint: 2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f.
     How it applies: The review calls bypass surgery and endovascular treatment the mainstream treatments for peripheral artery disease.
  5. Supports: Endovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2025;15), fetched 2026-11-18. A systematic review and meta-analysis. Used only for how the review describes the mainstream treatments for peripheral artery disease and its statement that the best approach is debated; its pooled odds ratios, hazard ratios and its conclusion are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC12786405/>
     Locator: 1. Introduction, para 2, sentence 2 (part). Retrieved 2026-11-18T17:27:07Z. Source state: Current. Version fingerprint: 2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f.
     How it applies: The review says the choice of treatment varies and the best approach has been a subject of ongoing controversy.
  6. Background: Endovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2025;15), fetched 2026-11-18. A systematic review and meta-analysis. Used only for how the review describes the mainstream treatments for peripheral artery disease and its statement that the best approach is debated; its pooled odds ratios, hazard ratios and its conclusion are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC12786405/>
     Locator: Abstract, Objectives, sentence 1. Retrieved 2026-11-18T17:27:07Z. Source state: Current. Version fingerprint: 2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f.
     How it applies: The review says guidelines widely recommend endovascular therapy for infrainguinal disease despite a lack of adequately powered data.
  7. Supports: Recent advances in endovascular treatment of peripheral arterial disease (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (F1000Research 2020;9), fetched 2026-11-18. A review article. Used only for what angioplasty and stents are in endovascular treatment of peripheral arterial disease; device results and regulatory comments in the review are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC7043107/>
     Locator: Percutaneous transluminal angioplasty, para 1, sentence 1 (end). Retrieved 2026-11-18T17:27:15Z. Source state: Current. Version fingerprint: fd265bf6666ee2c3b49cbbd613b6fb9cf135f1fc472ba2fd5ed9c2d43efe6b49.
     How it applies: Percutaneous transluminal angioplasty is described as one of the mainstays of endovascular therapy.
  8. Supports: Recent advances in endovascular treatment of peripheral arterial disease (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (F1000Research 2020;9), fetched 2026-11-18. A review article. Used only for what angioplasty and stents are in endovascular treatment of peripheral arterial disease; device results and regulatory comments in the review are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC7043107/>
     Locator: Endovascular stents, para 1, sentence 2. Retrieved 2026-11-18T17:27:15Z. Source state: Current. Version fingerprint: fd265bf6666ee2c3b49cbbd613b6fb9cf135f1fc472ba2fd5ed9c2d43efe6b49.
     How it applies: Stents have evolved to include bare metal stents, covered stents and drug-eluting stents.

## Connected pages

- Filed under this front: Procedures and surgery (`cardio:front-procedures-and-surgery`)
- Reviews describe bypass surgery and endovascular treatment as the mainstream treatments for peripheral artery disease; the best approach is debated: Peripheral artery disease (`cardio:peripheral-artery-disease`) [a claim, not a settled fact; see claim `cardio:claim-pad-revascularization-approaches` and its context]
- A review of chronic limb-threatening ischemia discusses revascularization and says not all patients are suitable for it: Chronic limb-threatening ischemia (`cardio:chronic-limb-threatening-ischemia`) [a claim, not a settled fact; see claim `cardio:claim-pad-revascularization-approaches` and its context]
- A review of endovascular treatment lists drug-eluting stents among the stent types: Drug-eluting stent (`cardio:drug-eluting-stent`)
- A review compares supervised exercise therapy with invasive measures such as endovascular and open revascularization: Supervised exercise therapy (`cardio:supervised-exercise-therapy`)

## Provenance

Content hash: 63115c116197cd6d66922008f9e5f11b0d7c2c0469861b80834f12479341ea47
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
